Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00243_DB00343_nanopub.RAbGgKOZaBFo71ZVX9l9s3Uuoey1Ki0CYHWEo7pNlbk0M#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00243_DB00343 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00243_DB00343 label "DDI between Ranolazine and Diltiazem - Diltiazem may increase the serum concentration of ranolazine. Consider alternate therapy or limit ranolazine dose to 500 mg twice daily and monitor for changes in the therapeutic and adverse effects if diltiazem is initiated, discontinued or dose changed. [drugbank_resource:DB00243_DB00343]" assertion.
- drugbank_resource:DB00243_DB00343 identifier "drugbank_resource:DB00243_DB00343" assertion.
- drugbank_resource:DB00243_DB00343 title "DDI between Ranolazine and Diltiazem - Diltiazem may increase the serum concentration of ranolazine. Consider alternate therapy or limit ranolazine dose to 500 mg twice daily and monitor for changes in the therapeutic and adverse effects if diltiazem is initiated, discontinued or dose changed." assertion.
- drugbank:DB00343 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00243_DB00343 assertion.
- drugbank:DB00243 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00243_DB00343 assertion.